Pharmacological Research

Article	Citations
An oncolytic system produces oxygen selectively in pancreatic tumor cells to alleviate hypoxia and improve immune activation	521
Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis	494
Corrigendum to ‘Dioscin attenuates renal ischemia/reperfusion injury by inhibiting the TLR4/MyD88 signaling pathway via up-regulation of HSP70′ [Pharmacol. Res. 100 (2015) 341–352]	246
Congenital diaphragmatic hernia increases the sensitivity of pulmonary arteries to nitric oxide	244
An account on the history of pharmacology in Spain	211
Gut-vascular axis and postbiotics: The need for clear definitions and further research	207
Impact of Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer’s disease	198
Molecular mechanisms of pyroptosis in non-alcoholic steatohepatitis and feasible diagnosis and treatment strategies	186
DNMT3a-mediated methylation of TCF21/hnRNPA1 aggravates hepatic fibrosis by regulating the NF-κB signaling pathway	185
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer	179
Natural HSP90 inhibitors as a potential therapeutic intervention in treating cancers: A comprehensive review	175
Piperlongumine synergistically enhances the antitumour activity of sorafenib by mediating ROS-AMPK activation and targeting CPSF7 in liver cancer	174
Time-dependent proteomics and drug response in expanding cancer cells	162
Simultaneously blocking ANGPTL3 and CD47 prevents the progression of atherosclerosis through regulating lipid metabolism, macrophagic efferocytosis and lipid peroxidation	161
Looking deeper into the findings of DARE-19: Failure or an open door to future success?	154
Response to letter to the editor: Letter by Chen et al. regarding article, “Assessment of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer's disease: A pop	149
Pharmacological rationale for the very early treatment of acute coronary syndrome with monoclonal antibodies anti-PCSK9	148
Fluvoxamine alleviates bleomycin-induced lung fibrosis via regulating the cGAS-STING pathway	144
Noncoding RNAs involved in DNA methylation and histone methylation, and acetylation in diabetic vascular complications	143
Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales	141
Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effect	140
Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein	134
ARID1A is a coactivator of STAT5 that contributes to CD8+ T cell dysfunction and anti-PD-1 resistance in gastric cancer	134
Quercetin encapsulated in folic acid-modified liposomes is therapeutic against osteosarcoma by non-covalent binding to the JH2 domain of JAK2 Via the JAK2-STAT3-PDL1	130
Unraveling the roles of miRNAs in regulating epithelial-to-mesenchymal transition (EMT) in osteosarcoma	129

G-protein biased signaling agonists of Dopamine D3 receptor promote distinct activation patterns of ERK1/2	129
Echinatin inhibits the growth and metastasis of human osteosarcoma cells through Wnt/β-catenin and p38 signaling pathways	124
Chimeric cytokine receptor TGF-β RⅡ/IL-21R improves CAR-NK cell function by reversing the immunosuppressive tumor microenvironment of gastric cancer	117
Phloretin ameliorates diabetes-induced endothelial injury through AMPK-dependent anti-EndMT pathway	116
Natural products targeting RAS by multiple mechanisms and its therapeutic potential in cancer: An update since 2020	116
Targeting regulated cell death in aortic aneurysm and dissection therapy	113
Polypharmacology: The science of multi-targeting molecules	112
Telmisartan reverses hepatic steatosis via PCK1 upregulation: A novel PPAR-independent mechanism in experimental models of MASLD	108
Komagataella pastoris KM71H modulates neuroimmune and oxidative stress parameters in animal models of depression: A proposal for a new probiotic with antidepressant-like effect	107
Genetic and pharmacological targeting of HINT2 promotes OXPHOS to alleviate inflammatory responses and cell necrosis in acute pancreatitis	104
Progress in the development of modulators targeting Frizzleds	100
Chromatin factors: Ready to roll as biomarkers in metastatic colorectal cancer?	99
Mitochondrial dysfunction and beneficial effects of mitochondria-targeted small peptide SS-31 in Diabetes Mellitus and Alzheimer’s disease	99
Relevance of mitochondrial oxidative stress to arrhythmias: Innovative concepts to target treatments	98
Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death	98
Upgrade of chrysomycin A as a novel topoisomerase II inhibitor to curb KRAS-mutant lung adenocarcinoma progression	98
The specific deletion of cyclooxygenase-1 in megakaryocytes/platelets reduces intestinal polyposis in Apc mice	97
The function and therapeutic potential of transfer RNA-derived small RNAs in cardiovascular diseases: A review	97
Efficacy of vitamin D supplementation as an adjunct therapy for improving inflammatory and oxidative stress biomarkers: An umbrella meta-analysis	96
Decoding the Metabolic-immune Axis: Neutrophil glycolysis-driven tumor niche remodeling and its therapeutic exploitation	93
NAFLD-associated hepatocellular carcinoma (HCC) – A compelling case for repositioning of existing mTORc1 inhibitors	93
Cordycepin alleviated metabolic inflammation in Western diet-fed mice by targeting intestinal barrier integrity and intestinal flora	92
Editorial Board	92
Hirsutine ameliorates hepatic and cardiac insulin resistance in high-fat diet-induced diabetic mice and in vitro models	90
Dual BET/HDAC inhibition to relieve neuropathic pain: Recent advances, perspectives, and future opportunities	89
Present and future antipsychotic drugs: A systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective	88
Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism	85
Molecular mechanisms underlying hepatoprotective activity of lutein in the context of intestinal failure-associated liver disease	85
Astaxanthin: A promising therapeutic agent for organ fibrosis	83
Combination of palbociclib with navitoclax based-therapies enhances in vivo antitumoral activity in triple-negative breast cancer	83
The role of exosomes derived from various sources in facilitating the healing of chronic refractory wounds	83
Research progress on the interaction between oxidative stress and platelets: Another avenue for cancer?	82
Therapeutic implications of sonic hedgehog pathway in metabolic disorders: Novel target for effective treatment	82
Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy	82
Corrigendum to ‘Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein’ [Pharmacol. Res. 175 (2022) 105975]	81
Pharmacological targeting of HMGB-1 translocation: A potential therapeutic strategy for COVID-19	81
Editorial Board	80
Elevated activity of plasma dipeptidyl peptidase 4 upon stress can be targeted to reverse tumor immunosuppression	78
Naphthoquinone derivatives as P-glycoprotein inducers in inflammatory bowel disease: 2D monolayers, 3D spheroids, and in vivo models	78
Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer	77
Sirtuin3 attenuates pressure overload-induced pathological myocardial remodeling by inhibiting cardiomyocyte cuproptosis	77
The natural product berberine synergizes with osimertinib preferentially against MET-amplified osimertinib-resistant lung cancer via direct MET inhibition	77
Functional metabolomics revealed the dual-activation of cAMP-AMP axis is a novel therapeutic target of pancreatic cancer	76
The major histocompatibility complex participates in Parkinson’s disease	74
IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT2A receptors in mouse models of chronic pain	73
Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy	73
Ferritin nanoconjugates guide trastuzumab brain delivery to promote an antitumor response in murine HER2 + breast cancer brain metastasis	73
Atrial fibrillation: Epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors	73
Blocking ANGPTL3 and CD47 impact on atherosclerosis-correspondence	72
Role of Angiopoietin-Tie axis in vascular and lymphatic systems and therapeutic interventions	72

Corrigendum to “Deficiency in adiponectin exaggerates cigarette smoking exposure-induced cardiac contractile dysfunction: Role of autophagy” [Pharm. Res. 100 (2015) 175–89]	72
Sailing south from regulations to strategies: Macau as a promising gateway for the export of proprietary Chinese medicines to ASEAN countries	72
Sex-dependent efficacy of sphingosine-1-phosphate receptor agonist FTY720 in mitigating Huntington’s disease	71
Profiling the impact of anti-human CD20 monoclonal antibodies on lymphocyte B cell subsets and their precursors in the bone marrow and in lymphoid tissues in an immunocompromised mouse engrafted with	71
Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy	70
Revisiting the renin-angiotensin-aldosterone system in the eye: Mechanistic insights and pharmacological targets	70
α1-adrenoceptor ligands inhibit chemokine receptor heteromerization partners of α1B/D-adrenoceptors via interference with heteromer formation	70
Multidisciplinary consensus on the diagnosis and management of patients with atypical Hemolytic Uremic Syndrome (complement-mediated TMA): Recommendations from Italian scientific societies, patient as	70
DNA repair biomarkers to guide usage of combined PARP inhibitors and chemotherapy: A meta-analysis and systematic review	69
Hydrogen sulfide regulates the redox state of soluble guanylate cyclase in CSE-/- mice corpus cavernosum microcirculation	67
Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease	67
AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy	65
The action of curcumin against damage resulting from cerebral stroke: A systematic review	65
Pharmacological targeting of microglia dynamics in Alzheimer’s disease: Preclinical and clinical evidence	65
Astrocyte-derived lactoferrin inhibits neuronal ferroptosis by reducing iron content and GPX4 degradation in APP/PS1 transgenic mice	65
ABCB1 and ABCG2 limit brain penetration and, together with CYP3A4, total plasma exposure of abemaciclib and its active metabolites	65
Metabolic disorders affecting the liver and heart: Therapeutic efficacy of miRNA-based therapies?	65
TAK1 blockade as a therapy for retinal neovascularization	65
The complementary and alternative roles of elemene injection in cancer: An umbrella review	65
Net clinical benefit of a reduced dose of DOACs in non-valvular atrial fibrillation: A meta-analysis of randomized trials	65
A copper nanocluster-based multifunctional nanoplatform for augmented chemo/chemodynamic/photodynamic combination therapy of breast cancer	65
Regulation of nicotinic acetylcholine receptors by post-translational modifications	65
A novel immune checkpoint siglec-15 antibody inhibits LUAD by modulating mφ polarization in TME	64
Protein-polysaccharide interactions for the fabrication of bioactive-loaded nanocarriers: Chemical conjugates and physical complexes	64
Evaluation of the analgesic effect of ɑ-lipoic acid in treating pain disorders: A systematic review and meta-analysis of randomized controlled trials	64
Hormesis: Wound healing and keratinocytes	63
Nasal accumulation and metabolism of Δ9-tetrahydrocannabinol following aerosol (‘vaping’) administration in an adolescent rat model	63
Proneurogenic and neuroprotective effect of a multi strain probiotic mixture in a mouse model of acute inflammation: Involvement of the gut-brain axis	63
Hormesis: wound healing and fibroblasts	63
A molecular perspective on mGluR5 regulation in the antidepressant effect of ketamine	62
Microsomal glutathione transferase 1 controls metastasis and therapeutic response in melanoma	62
Pharmacological targeting of G protein-coupled receptor heteromers	61
Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges	61
Ginsenoside Ro prevents endothelial injury via promoting Epac1/AMPK- mediated mitochondria protection in early diabetic retinopathy	61
Astrocytic connexin43 in the medial prefrontal cortex regulates depressive- and anxiety-like behaviors via ATP release	61
Medical treatment of weight loss in children and adolescents with obesity	61
Single-cell RNA sequencing highlights the roles of C1QB and NKG7 in the pancreatic islet immune microenvironment in type 1 diabetes mellitus	61
Targeted and cytotoxic inhibitors used in the treatment of lung cancers	60
Combining choline bitartrate and vitamin B12 ameliorates cognitive impairment in hypertensive elders with cognitive frailty	60
RNA-binding motif 4 promotes angiogenesis in HCC by selectively activating VEGF-A expression	59
Cannabinoid-mediated targeting of mitochondria on the modulation of mitochondrial function and dynamics	59
Lycorine improves peripheral nerve function by promoting Schwann cell autophagy via AMPK pathway activation and MMP9 downregulation in diabetic peripheral neuropathy	59
Mitochondria as an important target of metformin: The mechanism of action, toxic and side effects, and new therapeutic applications	59
Red blood cell-derived extracellular vesicles deliver NUP85 siRNA to alleviate MASLD through downregulating SLC27A1/PPAR-γ in hepatocyte	58
CircRNA in ocular neovascular diseases: Fundamental mechanism and clinical potential	58
Future directions for the discovery of natural product-derived immunomodulating drugs: an IUPHAR positional review	58
Expand available targets for CAR-T therapy to overcome tumor drug resistance based on the "Evolutionary Traps"	58
Role of hypoxia in cellular senescence	57
Remote ischemic conditioning attenuates blood-brain barrier disruption after recombinant tissue plasminogen activator treatment via reducing PDGF-CC	57
Commentary on “Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis”	56
Novel mesothelin-targeted chimeric antigen receptor-modified UNKT cells are highly effective in inhibiting tumor progression	56
IUPHAR editorial: Emerging targets for the treatment of pain: Moving towards non-addicting therapeutics and new preclinical directions	56
Gut microbiota-driven metabolic alterations reveal the distinct pathogenicity of chemotherapy-induced cachexia in gastric cancer	55
Alternative splicing: A key regulator in T cell response and cancer immunotherapy	55
The α9α10 acetylcholine receptor: A non-neuronal nicotinic receptor	55
Role for the F-box proteins in heart diseases	55
Targeting LRP6: A new strategy for cancer therapy	55
Systematic druggable genome-wide Mendelian randomization to identify therapeutic targets and dominant flora for ulcerative colitis	54
Corrigendum to “Ectopic expression of NKG7 enhances CAR-T function and improves the therapeutic efficacy in liquid and solid tumors” [Pharmacol. Res. 210 (2024) 107506]	54
New therapies towards a better glycemic control in youths with type 1 diabetes	53
Corrigendum to “A novel immune checkpoint siglec-15 antibody inhibits LUAD by modulating mφ polarization in TME” [Pharmacol. Res. 181 (2022) 106269]	53
Acute coronary syndrome and lipid-lowering therapy in a realistic diagnostic-therapeutic care pathway	53
Leveraging HER2-targeted biparatopic antibodies in solid tumors	53
Special Issue Spanish Basic and Clinical Pharmacology	52
Establishment of an inducible cell line for Hepatitis B virus genotype C2 and its pharmacological responses to interferons	52
Application of carbon monoxide in kidney and heart transplantation: A novel pharmacological strategy for a broader use of suboptimal renal and cardiac grafts	52
Treating COVID-19 with NRICM101 and NRICM102 – Author’s reply 3	52
Dietary lipid droplet structure in postnatal life improves hepatic energy and lipid metabolism in a mouse model for postnatal programming	52
Nanotheranostics in cancer lymph node metastasis: The long road ahead	51
Editorial Board	51
Editorial Board	51
Game-changer in the fight against Huntington's disease: Cholesterol nanoparticles restore brain function in mice	51
Manuka honey activates the aryl hydrocarbon receptor: Implications for skin inflammation	50
IUPHAR Review - Bivalent and bifunctional opioid receptor ligands as novel analgesics	50
Post-stroke administration of H2 relaxin reduces functional deficits, neuronal apoptosis and immune cell infiltration into the mouse brain	50
Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: A systematic review and meta-analysis of randomi	50
Zedoarondiol inhibits atherosclerosis by regulating monocyte migration and adhesion via CXCL12/CXCR4 pathway	50
Effects of exogenous melatonin supplementation on health outcomes: An umbrella review of meta-analyses based on randomized controlled trials	49
ER-organelle contacts: A signaling hub for neurological diseases	49
Potential of diterpenes as antidiabetic agents: Evidence from clinical and pre-clinical studies	49

A panel of altered blood oxysterols in patients with mild cognitive impairment: A novel combined diagnostic marker	49
Elucidation of the anti-inflammatory mechanism of Er Miao San by integrative approach of network pharmacology and experimental verification	49
Multitarget ligands that comprise opioid/nonopioid pharmacophores for pain management: Current state of the science	49
Mitochondria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR/SREBP-1 and NF-κB signaling pathway	49
Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond	49
Telmisartan induces a specific gut microbiota signature which may mediate its antiobesity effect	49
Functional significance of O-linked N-acetylglucosamine protein modification in regulating autophagy	48
Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE study	48
Efficacy and safety of Qingda granule versus valsartan capsule in Chinese grade 1 hypertensive patients with low-moderate risk: A randomized, double-blind, double dummy, non-inferiority, multi-center	47
Kallistatin leads to cognition impairment via downregulating glutamine synthetase	47
Preclinical development of a standardized extract of Ilex paraguariensis A.St.-Hil for the treatment of obesity and metabolic syndrome	47
Action and therapeutic targets of myosin light chain kinase, an important cardiovascular signaling mechanism	46
New therapeutic avenues in multiple sclerosis: Is there a place for gut microbiota-based treatments?	46
Gut microbiota and well-being: A comprehensive summary of the special issue	46
Design of the distribution of iron oxide (Fe3O4) nano-particle drug in realistic cholangiocarcinoma model and the simulation of temperature increase during magnetic induction hyperthermia	46
Neutrophils as potential therapeutic targets for breast cancer	46
Role of NSD1 as potential therapeutic target in tumor	46
Ferroportin 1 depletion in neural stem cells promotes hippocampal neurogenesis and cognitive function in mice	46
The interplay of aging, sleep dysregulation, and mitochondrial dysfunction in metabolic and neurodegenerative diseases	46
Perturbations of CB1 receptor signalling during adolescence impair cortical myelination in female rats	46
Therapeutic induction of energy metabolism reduces neural tissue damage and increases microglia activation in severe spinal cord injury	45
TRP channels in cancer: Therapeutic opportunities and research strategies	45
Corrigendum to “Paclitaxel-Ang-2-functionalized bionic mesoporous selenium nanoparticles for targeted therapy of glioma” [Pharmacol. Res. 216 (2025) 107783]	45
The role of androgens in women's health and wellbeing	45
Cucurbitacin B: A review of its pharmacology, toxicity, and pharmacokinetics	45
Garlic constituents for cancer prevention and therapy: From phytochemistry to novel formulations	45
Editorial Board	45
Ketogenic diet in children and adolescents: The effects on growth and nutritional status	44
Anticancer potential of allicin: A review	44
Polyol pathway and redox balance in diabetes	44
The role and potential mechanism of O-Glycosylation in gastrointestinal tumors	44
Therapeutical peptides - rapidly developing pharmaceutical landscape	44
Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis	44
Regulation of glycolysis-derived L-lactate production in astrocytes rescues the memory deficits and Aβ burden in early Alzheimer’s disease models	44
Anti-inflammatory and immunomodulatory activity of Mangifera indica L. reveals the modulation of COX-2/mPGES-1 axis and Th17/Treg ratio	44
MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis	44
Mtnr1b deletion disrupts placental angiogenesis through the VEGF signaling pathway leading to fetal growth restriction	43
Long noncoding RNA p21 enhances autophagy to alleviate endothelial progenitor cells damage and promote endothelial repair in hypertension through SESN2/AMPK/TSC2 pathway	43
Corrigendum to “Sugiol, a diterpenoid: Therapeutic actions and molecular pathways involved” Pharmacol. Res. 163 (2021) 105313	43
Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity	43
Anti-neuropathic pain activity of Ajugarin-I via activation of Nrf2 signaling and inhibition of TRPV1/TRPM8 nociceptors in STZ-induced diabetic neuropathy	43
Understanding the habenula: A major node in circuits regulating emotion and motivation	43
An ode to valproic acid: A letter to the editor	42
Corrigendum to “Dihydroartemisin inhibits glioma invasiveness via a ROS to P53 to β-catenin signaling” [Pharmacol. Res. 119 (2017) 72–88]	42
SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19	42
Editorial Board	42
A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing	42
Breaking through the treatment desert of conventional mesothelin-targeted CAR-T cell therapy for malignant mesothelioma: A glimpse into the future	42
Clinical trials of orphan drugs in China over the decade 2012–2022: Opportunities and challenges	42
Ginsenoside Rb1 and berberine synergistically protect against type 2 diabetes mellitus via GDF15/HAMP pathway throughout the liver lobules: Insights from spatial transcriptomics analysis	42
ABCB1 limits brain exposure of the KRASG12C inhibitor sotorasib, whereas ABCB1, CYP3A, and possibly OATP1a/1b restrict its oral availability	41
β-amyloid’s neurotoxic mechanisms as defined by in vitro microelectrode arrays: a review	41
Ginsenoside Rg1: A bioactive therapeutic agent for diverse liver diseases	41
Targeting regulated cell death (RCD) with naturally derived sesquiterpene lactones in cancer therapy	41
Topical VX-509 attenuates psoriatic inflammation through the STAT3/FABP5 pathway in keratinocytes	41
Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacy	41
Circulating cytokines and risk of developing hypertension: A systematic review and meta-analysis	41
Diabetic retinopathy in the pediatric population: Pathophysiology, screening, current and future treatments	40
Therapeutic effects of curcumin liposomes and nanocrystals on inflammatory osteolysis: In vitro and in vivo comparative study	40
Powering prescription: Mitochondria as “Living Drugs” – Definition, clinical applications, and industry advancements	40
Inhibition of long noncoding RNA Gm41724 alleviates pressure overload-induced cardiac fibrosis by regulating lamina-associated polypeptide 2α	40
Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models	40
Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions	40
ALOX5 inhibition protects against dopaminergic neurons undergoing ferroptosis	39
The potential role of mitochondria in the microbiota-gut-brain axis: Implications for brain health	39
Gut Clostridium sporogenes-derived indole propionic acid suppresses osteoclast formation by activating pregnane X receptor	39
Vanillic acid restores homeostasis of intestinal epithelium in colitis through inhibiting CA9/STIM1-mediated ferroptosis	39
A novel approach to explore metabolic diseases: Neddylation	39
AlphaFold-based AI docking reveals AMPK/SIRT1-TFEB pathway modulation by traditional Chinese medicine in metabolic-associated fatty liver disease	39
Gut microbiota-derived metabolite phenylacetylglutamine in cardiovascular and metabolic diseases	39
p53: A double-edged sword in tumor ferroptosis	39
Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?	38
A review of KLF4 and inflammatory disease: Current status and future perspective	38
The ketogenic diet modulates tumor-associated neutrophil polarization via the AMOT-YAP/TAZ axis to inhibit colorectal cancer progression	38
Biological activities, Molecular mechanisms, and Clinical application of Naringin in Metabolic syndrome	38
RNA methylation and cancer treatment	38
Crosstalk between extracellular vesicles and autophagy in cardiovascular pathophysiology	38
Circulating extracellular vesicles from patients with traumatic brain injury induce cerebrovascular endothelial dysfunction	38
Activation of PKM2 metabolically controls fulminant liver injury via restoration of pyruvate and reactivation of CDK1	38
Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB2R modulators in neurodegenerative diseases	38
Paracetamol metabolism by endothelial cells – Potential mechanism underlying intravenous paracetamol-induced hypotension	38
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment	38
Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway	37
BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: preclinical evaluation in a murine model of hind limb unloading	37
The AIM2 inflammasome: A novel biomarker and target in cardiovascular disease	37
Beyond metabolic messengers: Bile acids and TGR5 as pharmacotherapeutic intervention for psychiatric disorders	37
HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response	37
Corrigendum to “GPR37 promotes cancer growth by binding to CDK6 and represents a new theranostic target in lung adenocarcinoma”[Pharmacol. Res. 183 (2022) 106389]	36
D-arabinose acts as antidepressant by activating the ACSS2-PPARγ/TFEB axis and CRTC1 transcription	36
Corrigendum to “Modulation of the JAK/ERK/STAT signaling in melanocortin -induced inhibition of local and systemic responses to myocardial ischemia/reperfusion [Pharmacological Research 72 (2013) 1–8]	36
Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis	36
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges	36
A TRPV1 agonist from the transcriptome profiling of Dipsastraea rotumana inhibits neuroinflammation in vivo through the NF-κB and MAPK pathways	36
Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer	36
Corrigendum to “Anlotinib combined with osimertinib reverses acquired osimertinib resistance in NSCLC by targeting the c-MET/MYC/AXL axis” [Pharmacol. Res. 188 (2023) 106668]	36